top of page
GLP-1 Treatment for osteoarthritis of the Knee and obesity
Clinical Research Study


STUDY DETAILS
Now enrolling for a clinical research trial to help evaluate the effectiveness of an investigational GLP-1 injectable therapy vs a placebo on pain, mobility and weight loss in obese adults with osteoarthritis of the knee.
Qualifications
-
18+ years of age
-
Diagnosis of osteoarthritis of the knee
-
BMI >27
-
No diagnosis of kidney or liver disease
-
No type 1 or type 2 diabetes
-
Additional criteria may apply
What to Expect
-
75-week study commitment Kirkland, WA
-
Weekly self-injections of study treatment
-
Your study information and results are private and confidential
To participate please fill out the form below to be contacted by a member of our clinical research team.
Join our Participant List
Be notified of upcoming studies by joining our participant list.
bottom of page
